Which of the following is a biomarker of myocardial fibrosis? Correct answer: a) Soluble ST2 receptor Galectin-3 is another biomarker of myocardial fibrosis. Back to question Reference Yancy
Shock index and modified shock index for prediction of myocardial damage and clinical outcome of STEMI Shock index / modified shock index for STEMI clinical outcome prediction: Shock
Shock index and pediatric specific shock index Shock index is a simple bedside measure introduced by Allgower and associates [1] as early as 1967. Shock index is the
Why is not neprilysin inhibitor used alone? – Discussion Neprilysin is a neutral endopeptidase involved in the degradation of natriuretic peptides (A, B and C), bradykinin, adrenomedullin, angiotensin
While switching over from an ACE inhibitor to ARNI, ARNI can be started — hours after ACEI: Correct answer: c) 36 hours Combination of ACEI (angiotensin converting enzyme inhibitor)
In ARNI (Angiotensin receptor blocker+ neprilysin inhibitor), why is ARB (Angiotensin receptor blocker) combined with the neprilysin inhibitor? To be exact, what is the disadvantage of giving neprilysin
Guideline recommended treatment for heart failure with preserved ejection fraction (HFpEF) Heart failure with preserved ejection fraction (HFpEF) is becoming a well recognized entity, occurring more often in
Which of the following is a biomarker of myocardial fibrosis? a) Soluble ST2 receptor b) Troponin I c) NT-pro BNP d) BNP Please click here for the correct
Will you estimate BNP or NT-proBNP (N-terminal pro-B-type natriuretic peptide) while on ARNI? BNP (B-type natriuretic peptide) and NT-proBNP are commonly estimated biomarkers for heart failure. They have
